Autonomix Medical, Inc.
AMIX
$1.01
$0.000.00%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 2.21% | 26.89% | 79.28% | 292.17% | 360.05% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 30.98% | 55.02% | 88.10% | 227.61% | 279.41% |
| Operating Income | -30.98% | -55.02% | -88.10% | -227.61% | -279.41% |
| Income Before Tax | 30.20% | 26.04% | -27.64% | -73.04% | -601.57% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 30.20% | 26.04% | -27.64% | -73.04% | -601.57% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 30.20% | 26.04% | -27.64% | -73.04% | -601.57% |
| EBIT | -30.98% | -55.02% | -88.10% | -227.61% | -279.41% |
| EBITDA | -51.56% | -115.91% | -262.98% | -- | -- |
| EPS Basic | 67.03% | 59.12% | 24.49% | -2.25% | -368.39% |
| Normalized Basic EPS | 67.03% | 59.12% | 24.48% | -2.25% | -368.39% |
| EPS Diluted | 67.03% | 59.12% | 24.49% | -2.25% | -368.39% |
| Normalized Diluted EPS | 67.03% | 59.12% | 24.48% | -2.25% | -368.39% |
| Average Basic Shares Outstanding | 116.27% | 98.52% | 82.26% | 78.97% | 67.03% |
| Average Diluted Shares Outstanding | 116.27% | 98.52% | 82.26% | 78.97% | 67.03% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |